• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

解析 CUL3 引起的家族性高钾血症性高血压的多种机制和作用。

Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.

机构信息

NIH Undiagnosed Diseases Program, Common Fund, Office of the Director, National Institutes of Health, Bethesda, MD, USA.

College of Medicine, University of Arkansas for Medical Sciences, Little Rock, AR, USA.

出版信息

Cell Commun Signal. 2023 Oct 16;21(1):286. doi: 10.1186/s12964-023-01269-z.

DOI:10.1186/s12964-023-01269-z
PMID:37845702
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC10577937/
Abstract

Familial hyperkalemic hypertension (FHHt), also known as Pseudohypoaldosteronism type II (PHAII) or Gordon syndrome is a rare Mendelian disease classically characterized by hyperkalemia, hyperchloremic metabolic acidosis, and high systolic blood pressure. The most severe form of the disease is caused by autosomal dominant variants in CUL3 (Cullin 3), a critical subunit of the multimeric CUL3-RING ubiquitin ligase complex. The recent identification of a novel FHHt disease variant of CUL3 revealed intricacies within the underlying disease mechanism. When combined with studies on canonical CUL3 variant-induced FHHt, these findings further support CUL3's role in regulating renal electrolyte transport and maintaining systemic vascular tone. However, the pathophysiological effects of CUL3 variants are often accompanied by diverse systemic disturbances in addition to classical FHHt symptoms. Recent global proteomic analyses provide a rationale for these systemic disturbances, paving the way for future mechanistic studies to reveal how CUL3 variants dysregulate processes outside of the renovascular axis. Video Abstract.

摘要

家族性高血钾型高血压(FHHt),又称假性醛固酮减少症Ⅱ型(PHAII)或 Gordon 综合征,是一种罕见的孟德尔疾病,其特征为高血钾、高氯性代谢性酸中毒和收缩压升高。该疾病的最严重形式是由 CUL3(Cullin 3)的常染色体显性变异引起的,CUL3 是多聚体 CUL3-RING 泛素连接酶复合物的关键亚基。最近发现的一种新型 FHHt 疾病变体的 CUL3,揭示了潜在疾病机制的复杂性。当与对经典 CUL3 变体引起的 FHHt 的研究相结合时,这些发现进一步支持了 CUL3 在调节肾脏电解质转运和维持全身血管张力中的作用。然而,CUL3 变体的病理生理效应通常伴随着除经典 FHHt 症状以外的多种全身紊乱。最近的全球蛋白质组学分析为这些全身紊乱提供了依据,为未来的机制研究铺平了道路,以揭示 CUL3 变体如何使肾血管轴以外的过程失调。视频摘要。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10577937/397e004f30d5/12964_2023_1269_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10577937/b2996b64489d/12964_2023_1269_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10577937/81d326fbfc1f/12964_2023_1269_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10577937/397e004f30d5/12964_2023_1269_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10577937/b2996b64489d/12964_2023_1269_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10577937/81d326fbfc1f/12964_2023_1269_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/bdb2/10577937/397e004f30d5/12964_2023_1269_Fig3_HTML.jpg

相似文献

1
Insights into the diverse mechanisms and effects of variant CUL3-induced familial hyperkalemic hypertension.解析 CUL3 引起的家族性高钾血症性高血压的多种机制和作用。
Cell Commun Signal. 2023 Oct 16;21(1):286. doi: 10.1186/s12964-023-01269-z.
2
Novel Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity.新型变异导致家族性高血钾性高血压,损害泛素连接酶活性的调节和功能。
Hypertension. 2022 Jan;79(1):60-75. doi: 10.1161/HYPERTENSIONAHA.121.17624. Epub 2021 Dec 2.
3
Cullin 3 mutant causing familial hyperkalemic hypertension lacks normal activity in the kidney.导致家族性高血钾性高血压的 Cullin 3 突变体在肾脏中缺乏正常活性。
Am J Physiol Renal Physiol. 2022 Nov 1;323(5):F564-F576. doi: 10.1152/ajprenal.00153.2022. Epub 2022 Aug 25.
4
Mechanisms and controversies in mutant Cul3-mediated familial hyperkalemic hypertension.突变 Cul3 介导的家族性高钾血症性高血压的机制和争议。
Am J Physiol Renal Physiol. 2018 May 1;314(5):F915-F920. doi: 10.1152/ajprenal.00593.2017. Epub 2018 Jan 17.
5
Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.联合 Kelch-like 3 和 Cullin 3 降解是小鼠家族性高钾血症性高血压的核心机制。
J Am Soc Nephrol. 2022 Mar;33(3):584-600. doi: 10.1681/ASN.2021081099. Epub 2022 Jan 21.
6
Distal convoluted tubule-specific disruption of the COP9 signalosome but not its regulatory target cullin 3 causes tubular injury.远端卷曲小管特异性破坏 COP9 信号小体,但不破坏其调节靶标 Cullin3,导致管状损伤。
Am J Physiol Renal Physiol. 2024 Oct 1;327(4):F667-F682. doi: 10.1152/ajprenal.00138.2024. Epub 2024 Aug 29.
7
ROMK expression remains unaltered in a mouse model of familial hyperkalemic hypertension caused by the CUL3Δ403-459 mutation.在由CUL3Δ403 - 459突变引起的家族性高钾性高血压小鼠模型中,ROMK表达保持不变。
Physiol Rep. 2016 Jul;4(13). doi: 10.14814/phy2.12850.
8
Mutant Cullin 3 causes familial hyperkalemic hypertension via dominant effects.突变 Cullin 3 通过显性效应导致家族性高钾血症性高血压。
JCI Insight. 2017 Dec 21;2(24):96700. doi: 10.1172/jci.insight.96700.
9
Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling.Cullin 3 外显子 9 缺失导致家族性高钾血症性高血压,损害 Cullin3-环 E3 连接酶 (CRL3) 的动态调控和循环。
Int J Mol Sci. 2022 May 5;23(9):5151. doi: 10.3390/ijms23095151.
10
Degradation by Cullin 3 and effect on WNK kinases suggest a role of KLHL2 in the pathogenesis of Familial Hyperkalemic Hypertension.Cullin 3介导的降解及其对WNK激酶的影响表明KLHL2在家族性高钾性高血压发病机制中发挥作用。
Biochem Biophys Res Commun. 2016 Jan 1;469(1):44-48. doi: 10.1016/j.bbrc.2015.11.067. Epub 2015 Nov 23.

引用本文的文献

1
Familial Hyperkalemic Hypertension.家族性高钾性高血压
Compr Physiol. 2024 Dec 19;14(5):5839-5874. doi: 10.1002/cphy.c240004.
2
Cullin-3 proteins be a novel biomarkers and therapeutic targets for hyperchloremia induced by oral poisoning.Cullin-3 蛋白可能成为高氯血症的新型生物标志物和治疗靶点,高氯血症是由口服中毒引起的。
Sci Rep. 2024 Apr 13;14(1):8597. doi: 10.1038/s41598-024-59264-4.

本文引用的文献

1
The serine-threonine protein phosphatases that regulate the thiazide-sensitive NaCl cotransporter.调节噻嗪类敏感型氯化钠协同转运蛋白的丝氨酸-苏氨酸蛋白磷酸酶。
Front Physiol. 2023 Feb 15;14:1100522. doi: 10.3389/fphys.2023.1100522. eCollection 2023.
2
Double synonymous mutations in exon 9 of the Cullin3 gene restore exon inclusion by abolishing hnRNPs inhibition.Cullin3 基因exon9 中的双同义突变通过消除 hnRNPs 的抑制作用恢复外显子的包含。
Hum Mol Genet. 2022 Nov 28;31(23):4006-4018. doi: 10.1093/hmg/ddac148.
3
Cullin 3 Exon 9 Deletion in Familial Hyperkalemic Hypertension Impairs Cullin3-Ring-E3 Ligase (CRL3) Dynamic Regulation and Cycling.
Cullin 3 外显子 9 缺失导致家族性高钾血症性高血压,损害 Cullin3-环 E3 连接酶 (CRL3) 的动态调控和循环。
Int J Mol Sci. 2022 May 5;23(9):5151. doi: 10.3390/ijms23095151.
4
Endothelial Cullin3 Mutation Impairs Nitric Oxide-Mediated Vasodilation and Promotes Salt-Induced Hypertension.内皮细胞 Cullin3 突变损害一氧化氮介导的血管舒张并促进盐诱导的高血压。
Function (Oxf). 2022 Apr 8;3(3):zqac017. doi: 10.1093/function/zqac017. eCollection 2022.
5
Pseudohypoaldosteronism type 2: CUL3 mutation confirmed 15 years following initial diagnosis.2型假性醛固酮减少症:初始诊断15年后证实存在CUL3基因突变。
Intern Med J. 2022 Apr;52(4):691-692. doi: 10.1111/imj.15740.
6
Combined Kelch-like 3 and Cullin 3 Degradation is a Central Mechanism in Familial Hyperkalemic Hypertension in Mice.联合 Kelch-like 3 和 Cullin 3 降解是小鼠家族性高钾血症性高血压的核心机制。
J Am Soc Nephrol. 2022 Mar;33(3):584-600. doi: 10.1681/ASN.2021081099. Epub 2022 Jan 21.
7
Novel Variant Causing Familial Hyperkalemic Hypertension Impairs Regulation and Function of Ubiquitin Ligase Activity.新型变异导致家族性高血钾性高血压,损害泛素连接酶活性的调节和功能。
Hypertension. 2022 Jan;79(1):60-75. doi: 10.1161/HYPERTENSIONAHA.121.17624. Epub 2021 Dec 2.
8
The variety of genetic defects explains the phenotypic heterogeneity of Familial Hyperkalemic Hypertension.多种基因缺陷解释了家族性高钾性高血压的表型异质性。
Kidney Int Rep. 2021 Aug 2;6(10):2639-2652. doi: 10.1016/j.ekir.2021.07.025. eCollection 2021 Oct.
9
Gordon syndrome caused by a mutation in a patient with short stature in Korea: a case report.韩国一名身材矮小患者因 突变导致的 Gordon 综合征:病例报告。
J Pediatr Endocrinol Metab. 2021 Sep 6;35(2):253-257. doi: 10.1515/jpem-2021-0361. Print 2022 Feb 23.
10
Regulatory control of the Na-Cl co-transporter NCC and its therapeutic potential for hypertension.钠-氯共转运体NCC的调节控制及其在高血压治疗中的潜力。
Acta Pharm Sin B. 2021 May;11(5):1117-1128. doi: 10.1016/j.apsb.2020.09.009. Epub 2020 Sep 22.